Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at whether a digital support tool can help people with Treatment Resistant Depression. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with depression or anxiety. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Depression, Anxiety, Ptsd, or Intimate Partner Violence. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Depression, Brain Diseases, Central Nervous System Diseases, or Nervous System Diseases. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Celecoxib 400mg with placebo for people with major depression or Inflammation. Participants receive Celecoxib 400mg or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with depression or Loneliness. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Depression Mild or moderate depression. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether a digital support tool can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) can help people with Depression, HIV-1-infection, or Inflammation. Participants take part in Cognitive-Behavioral Therapy for Adherence and Depression (CBT-AD) and complete follow-up assessments.
This study is looking at whether Sham-stimulation can help people with Treatment Resistant Depression. Participants take part in Sham-stimulation and complete follow-up assessments.
This study is looking at estimate, from a collective point of view, the incremental cost-utility ratio of VNS to treat patients suffering from RD for people with Treatment Resistant Depression. Participants take part in a digital support tool and complete follow-up assessments.
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.